Health and biotech

Ascletis Pharma歌礼制药

Standard profile, compiled by hangzhou.be from public sourcesbiotechobesityGLP-1Xiaoshan

About the company

Ascletis Pharma develops drugs for metabolic diseases such as obesity and diabetes, including once-daily oral GLP-1 receptor agonists and long-acting injectable peptides. Its founder, chairman and chief executive is Dr Wu Jinzi. Its Hangzhou company is based at the Hangzhou Bay Information Port in Xiaoshan District, with a further company in Shaoxing, and its shares trade in Hong Kong. In 2026 Ascletis presented preclinical data at the EASD diabetes congress on a peptide combination designed for monthly to quarterly injection.

Video

No video yet. A company video is an add-on for companies with a profile.

Presentation

No presentation yet. A company presentation is an add-on for companies with a profile.

News

No news yet. Once the company claims its profile, hangzhou.be follows the news on the company website and whatever the company approves appears here.

Partnerships on hangzhou.be

No confirmed partnerships yet. A partnership only appears once both companies confirm it.

More in this sector: Health and biotech

Betta Pharmaceuticals贝达药业Betta Pharmaceuticals develops and sells cancer drugs, led by icotinib (Conmana), a targeted therapy for lung cancer.Hangzhou Minsheng Pharmaceutical杭州民生药业Hangzhou Minsheng Pharmaceutical makes medicines and vitamin products, including the 21 Super-Vita multivitamin brand and drugs for cancer, cardiovascular and digestive diseases.Hu Qing Yu Tang胡庆余堂Hu Qing Yu Tang makes traditional Chinese medicines and runs a historic pharmacy on Hefang Street that also houses a museum of traditional Chinese medicine.Huadong Medicine华东医药Huadong Medicine makes and distributes medicines, including immunosuppressants and endocrine, digestive, cardiovascular and cancer drugs, and also sells medical-aesthetics products.

Go to the full company directory: 100 companies and institutions